Neogen Announces the Appointment of New Board Member

Rhea-AI Summary

Neogen (NASDAQ: NEOG) has announced the appointment of Thierry Bernard as a new director to its Board, effective November 1, 2024. Bernard, the current CEO of QIAGEN N.V., brings extensive experience in science and technologies relevant to Neogen's markets. Jim Borel, Neogen's Board Chair, expressed confidence that Bernard's expertise will provide significant value during the company's continued growth.

Bernard has been CEO of QIAGEN since March 2020, after joining the company in 2015. His prior experience includes 15 years at bioMérieux SA, where he held various senior roles, including Corporate Vice President of Global Commercial Operations, Investor Relations, and the Greater China Region. This appointment aligns with Neogen's commitment to enhancing global food security.

Positive

• Appointment of an experienced industry leader to the Board of Directors
• New director brings relevant expertise in science and technologies
• Potential for valuable guidance during company's growth phase

Negative

• None.

LANSING, Mich., Oct. 1, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has appointed Thierry Bernard as a director to its Board, effective November 1, 2024.

"We are pleased to welcome Thierry Bernard to the Neogen Board of Directors and look forward to his guidance as the company continues in its commitment to fueling a brighter future for global food security," said Jim Borel, Neogen's Board Chair. "As a sitting CEO with a wealth of knowledge in science and technologies relevant to Neogen and its markets, we are confident that he will provide significant value to the Board during the company's continued growth." 

Thierry Bernard is Chief Executive Officer of QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA), a leading global provider of sample-to-insight solutions that are used to transform biological materials into molecular insights. Mr. Bernard was named to the role in March 2020 after joining QIAGEN in 2015. Prior to his role at QIAGEN, Mr. Bernard spent 15 years with bioMérieux SA, where he held roles of increasing responsibility, most recently as Corporate Vice President, Global Commercial Operations, Investor Relations and the Greater China Region. He also held senior management roles in other leading international companies.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Contact 
PR@Neogen.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-announces-the-appointment-of-new-board-member-302263825.html

SOURCE Neogen Corporation

FAQ

Who is the new board member appointed to Neogen (NEOG)?

Thierry Bernard, the current CEO of QIAGEN N.V., has been appointed as a new director to Neogen 's Board, effective November 1, 2024.

What is Thierry Bernard's background before joining Neogen's (NEOG) board?

Thierry Bernard is the CEO of QIAGEN N.V. since March 2020. He previously spent 15 years at bioMérieux SA, holding senior roles including Corporate Vice President of Global Commercial Operations, Investor Relations, and the Greater China Region.

When will Thierry Bernard join Neogen 's (NEOG) Board of Directors?

Thierry Bernard will join Neogen 's Board of Directors effective November 1, 2024.

How does Neogen (NEOG) expect to benefit from Thierry Bernard's appointment?

Neogen expects Thierry Bernard to provide significant value to the Board during the company's continued growth, leveraging his expertise in science and technologies relevant to Neogen's markets.